The development of medical AI market is amazing.

"At home and abroad, medical AI is developing at an alarming rate." A few days ago, Caixin Health point and philips issued a joint "China Medical Artificial Intelligence Industry Report" (hereinafter referred to as the "Report") pointed out that in recent years, a large number of medical artificial intelligence start-ups have emerged in China's medical market, at the same time, many traditional medical related enterprises and Internet platforms are also in riots. Artificial intelligence talents and technology are introduced into the relevant layout. With the rapid development of information technology

While combing the current situation of medical artificial intelligence industry, the report investigates dozens of domestic medical artificial intelligence enterprises. On the one hand, it makes in-depth analysis of typical enterprises, on the other hand, it forecasts the latest development trend of the industry through comprehensive research. Zhao Guochuang, Chief Operating Officer of Caixin Health point, believes that medical artificial intelligence has innate advantages in China: on the one hand, China's huge population and abundant medical data provide a cornerstone for the development of medical artificial intelligence; on the other hand, China's large enough medical market also provides a driving force for AI enterprises.Software-Defined Wide Area Networking (SD-WAN) is a transformational approach to simplify branch office networking and assure optimal application performance.

According to the Foresight Industry Research Institute's Analysis Report on the Market Foresight and Investment Strategic planning of China's Artificial Intelligence Industry from 2018 to 2023, the market size of China's medical Absolute Neutrophil Countartificial intelligence industry has reached 9.661 billion yuan in 2016 and is expected to reach 20 billion yuan in 2018.

According to statistics, from 2013 to 2017, China's medical AI industry received 241 financing. Among them, in 2017, the domestic medical artificial intelligence industry announced nearly 30 financing incidents, the total amount of financing more than 1.8 billion yuan. By 2018, capital's enthusiasm for the medical artificial intelligence market remained unchanged, with 18 companies invested in the first half of the year alone, totaling more than $3.1 billion. Moreover, the Internet giant has already paid a lot of money to lay out medical artificial intelligence, and has expanded its business to the upstream and downstream of the industrial chain.

"Report" analysis of the business model of medical artificial intelligence, medical artificial intelligence in the hot development, ushered in a critical period of commercialization. At present, although most of the medical artificial intelligence enterprises have not realized profitability, and most of the products are still in the experimental stage, but through different business models have been able to achieve a certain payment income.

According to the report, there are three types of companies engaged in medical artificial intelligence related business in China: start-ups, Internet platforms and traditional medical related enterprises. Because of the advantages and disadvantages of the three, business models are different. Startups often cooperate with insurance and medical institutions to sell services; Internet giants are speeding up the distribution of medical artificial intelligence, but international giants such as Facebook, Apple and Amazon pay less attention to cross-border projects in the medical industry, while domestic companies such as BAT and HKUST pay more attention to the market.

However, with the development of medical AI industry, the problems it faces are becoming increasingly prominent. The first is lack of standards, followed by the lack of AI talents. In China, there is a shortage of compound and strategic talents who know both medicine and technology.